Provided by Tiger Trade Technology Pte. Ltd.

Halozyme Therapeutics

108.17
+2.051.93%
Post-market: 108.170.00000.00%19:42 EDT
Volume:1.15M
Turnover:124.20M
Market Cap:12.28B
PE:31.98
High:108.49
Open:106.20
Low:105.91
Close:106.12
52wk High:108.49
52wk Low:61.23
Shares:113.50M
Float Shares:112.00M
Volume Ratio:0.58
T/O Rate:1.03%
Dividend:- -
Dividend Rate:- -
EPS(TTM):3.38
EPS(LYR):2.56
ROE:173.67%
ROA:25.49%
PB:85.53
PE(LYR):42.25

Loading ...

China's High-Barrier "HALO Assets" Offer Global Scarcity, Says Morgan Stanley Economist

Deep News
·
Jul 17

Halozyme CEO Helen Torley Disposes of 1,923 Common Shares Worth $146,852.55

Reuters
·
Jul 10

Goldman Sachs Revives "HALO Trade" Concept, Signaling a New Phase

Deep News
·
Jul 08

Halozyme Appoints David Ramsay as President Drug Delivery

Reuters
·
Jul 06

Stocks to Watch: Seer, Orthofix Medical, Halozyme Therapeutics

Dow Jones
·
Jul 03

Halozyme Director Bernadette Connaughton Sells 1,625 Shares Worth $124,370.63

Reuters
·
Jul 03

Halozyme Therapeutics Operating Chief Caudill to Exit

Dow Jones
·
Jul 03

Halozyme COO Cortney Caudill Departs Amid Senior Management Restructure

Reuters
·
Jul 03

Halozyme Director Mahesh Krishnan Disposes of 7,304 Shares for $547,800

Reuters
·
Jul 01

Halozyme Names David Ramsay President of Drug Delivery Unit

Reuters
·
Jul 01

Halozyme Appoints David Ramsay as President Drug Delivery

THOMSON REUTERS
·
Jul 01

LifeMD partners with Halozyme unit Antares to launch XYOSTED telehealth self-pay program in July 2026

Reuters
·
Jun 22

Halozyme Therapeutics Expects Proposed Rule to Have Little Impact on Royalties

MT Newswires Live
·
Jun 15

Analysts Conflicted on These Healthcare Names: Incyte (INCY), Intellia Therapeutics (NTLA) and Halozyme (HALO)

TIPRANKS
·
Jun 15

Halozyme sees zero to minimal royalty hit through at least 2035 under draft Medicare drug pricing rule

Reuters
·
Jun 15

Halozyme Confirms It Projects Zero to Minimal Impact to Royalty Revenue Through at Least 2035 Based on Newly Released Draft Medicare Drug Price Negotiation Program Proposed Rule for Ipay 2029

THOMSON REUTERS
·
Jun 15

Halozyme names Darren Snellgrove SVP, CFO in initial beneficial ownership filing

Reuters
·
Jun 10

Halozyme CEO Helen Torley disposes of USD 2.98 million in common shares

Reuters
·
Jun 04

Halozyme publishes 2025 greenhouse gas accounting summary report

Reuters
·
Jun 04

Yang Delong: Allocating to Technology and HALO Assets, Focusing on Opportunities in the "Six Major Tracks"

Deep News
·
Jun 03